In8bio Inc Stock Investor Sentiment

INAB Stock  USD 0.23  0.02  8.00%   
About 61% of In8bio's investor base is looking to short. The analysis of the overall investor sentiment regarding In8bio Inc suggests that many traders are alarmed. The current market sentiment, together with In8bio's historical and current headlines, can help investors time the market. In addition, many technical investors use In8bio Inc stock news signals to limit their universe of possible portfolio assets.
  
2 days ago at news.google.com         
INAB stock touches 52-week low at 0.22 amid sharp annual decline - Investing.com India
Google News at Macroaxis
3 days ago at gurufocus.com         
IN8bio Inc Reports Q4 2024 EPS of -0.08, Aligns with Estimates Revenue Remains at 0 Million
Gurufocus Stories at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Kreis Leslie W. of 574241 shares of In8bio at 1.5 subject to Rule 16b-3
Macroaxis News
over a week ago at finance.yahoo.com         
IN8bio Announces Advanced Gamma-Delta T cell Engager Platform for Oncology and Autoimmune Diseases
Yahoo News
over a week ago at gurufocus.com         
IN8bio Announces Advanced Gamma-Delta T cell Engager Platform for Oncology and ...
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
IN8bio, Inc. Short Interest Up 768.0 percent in February
news
over two weeks ago at news.google.com         
Can IN8bios Gamma-Delta T Cell Therapies Disrupt Cancer Treatment CEO to Reveal Strategy Next Week -...
Google News at Macroaxis
over two weeks ago at gurufocus.com         
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
INAB Continued Survival in INB-100 Trial
Yahoo News
over three weeks ago at thelincolnianonline.com         
Short Interest in IN8bio, Inc. Decreases By 51.9
news
over three weeks ago at gurufocus.com         
Alyeska Investment Group, L.P. Acquires Additional Shares in IN8bio Inc
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
IN8bio, Inc. Reports Positive Results from Ongoing Phase 1 Trial of INB-100 in Leukemia Patients New...
news
over three weeks ago at gurufocus.com         
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in ...
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
IN8bios INB-100 Shows Promising Results in AML Treatment, Analyst Recommends Buy with 8 Price Target...
Google News at Macroaxis
over a month ago at gurufocus.com         
IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about In8bio that are available to investors today. That information is available publicly through In8bio media outlets and privately through word of mouth or via In8bio internal channels. However, regardless of the origin, that massive amount of In8bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of In8bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of In8bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to In8bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive In8bio alpha.

In8bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for In8bio Stock analysis

When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device